Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status

ConclusionPredicting the occurrence of RAIR-disease in DTC patients may allow clinicians to focus on systemic redifferentiating strategies and/or local treatments for metastatic lesions rather than pursuing with ineffective RAI-therapies.
Source: Journal of Endocrinological Investigation - Category: Endocrinology Source Type: research